Retaglutide is a novel GLP-1 receptor agonist currently under study for the management of type 2 diabetes. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://haimajpzm713335.aioblogs.com/91655861/semaglutide-a-potential-solution-for-obesity